MERCK & CO. INC. (MRK) Stock Price, Quote, News and Overview
NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock - Currency: USD
MRK Quote, Performance and Key Statistics
MERCK & CO. INC.
NYSE:MRK (2/5/2025, 6:43:34 PM)
After market: 89.87 +0.2 (+0.22%)89.67
-1.07 (-1.18%)
The current stock price of MRK is 89.67 USD. In the past month the price decreased by -10.08%. In the past year, price decreased by -28.52%.
MRK Latest News, Press Releases and Analysis
Uncover the latest developments among S&P500 stocks in today's session.
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.
Looking for the most active stocks in the S&P500 index on Tuesday?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Discover which S&P500 stocks are making waves on Tuesday.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a lower-than-expected 2025 outlook.
Merck’s Gardasil Halt Shows Blockbuster Shots’ Dilemma in China
Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US pharmaceutical giant made the call earlier this week to halt shipments.
MRK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.96B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
| PFE | PFIZER INC | 8.5 | 149.84B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
| ZTS | ZOETIS INC | 30.5 | 79.26B | ||
| GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6.91 | 19.50B |
Related stock screener links
About MRK
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 72,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Company Info
MERCK & CO. INC.
126 East Lincoln Avenue
Rahway NEW JERSEY 07033 US
CEO: Kenneth C. Frazier
Employees: 72000
Company Website: https://www.merck.com/
Investor Relations: https://www.merck.com/investor-relations
Phone: 19087404000
MRK FAQ
What is the stock price of MRK?
The current stock price of MRK is 89.67 USD.
What is the symbol for MERCK & CO. INC. stock?
The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is MRK stock listed?
MRK stock is listed on the New York Stock Exchange, Inc. exchange.
Is MRK a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MRK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MRK.
Does MRK stock pay dividends?
MRK has a dividend yield of 3.25%. The yearly dividend amount is currently 2.94.
What is the Price/Earnings (PE) ratio of MRK?
The PE ratio for MRK is 11.74. This is based on the reported non-GAAP earnings per share of 7.64 and the current share price of 89.67 USD.
What is the Short Interest ratio of MRK stock?
The outstanding short interest for MRK is 1.35% of its float.
MRK Technical Analysis
MRK Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MRK. MRK has an excellent profitability rating, but there are some minor concerns on its financial health.
MRK Financial Highlights
Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.64. The EPS decreased by 409.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.23% | ||
| ROA | 10.34% | ||
| ROE | 27.3% | ||
| Debt/Equity | 0.79 |
MRK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to MRK. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 17% and a revenue growth 4.95% for MRK